Search
Merck & Co Inc
MRKAdd to Watchlist
146.940USD
-3.420-2.27%
Close 11-05 16:00（ET）
362.53BMarket Cap
41.17P/E TTM
After-hours 19:36 (ET)146.090USD-0.660-0.45%
After-hours 19:36 (ET)Merck & Co Inc (MRK) Stock Price Target & Forecast
Analyst Rating
Based on 31 analysts giving stock ratings to Merck & Co Inc in the past month.
Buy
7 Strong Buy
16 Buy
8 Hold
0 Sell
0 Strong Sell
Target Price
157.011USD+5.01%
MRK Analyst Recommendation Trends
In the current month, MRK has received 16 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. MRK average Analyst price target in the last month is 157.011.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
7
7
8
8
8
7
7
7
16
16
14
14
14
15
14
14
8
8
10
10
10
9
10
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
31
32
32
32
31
31
32
MRK Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
6
15
9
0
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, MRK EPS is projected to reach 1.746 in FY2026Q4, following reported EPS of 2.052 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-1.51
-0.27
2.08
1.75
2.13
Actual
-1.72
-0.54
2.05
--
--
Surprise
-13.69%
-100.18%
-1.38%
--
--
FAQs
What is Merck & Co Inc's expected revenue for the next quarter?
Merck & Co Inc's expected revenue is 16.29B.
What is Merck & Co Inc's price target?
Analysts forecast that Merck & Co Inc's price target is USD 157.01, with the highest forecast at USD 186.00 and the lowest forecast at USD 105.00.
How have Merck & Co IncMRK's recent earnings per share performed?
The market expectation was USD 2.05, while Merck & Co IncMRK's earnings per share (EPS) for the previous quarter was USD -0.54. EPS for the next quarter is expected at USD 1.75.
What is the analyst rating for Merck & Co Inc?
Based on the ratings of Merck & Co Inc's stock from 31 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.